Building Supply Chain Infrastructure for Cell and Gene Therapies

At another interview stop along Pharma’s Almanac’s Road to 2021 trip, Matthew Lakelin, TrakCel’s Vice President of Scientific Affairs and Business Development, discusses the infrastructure challenges facing the commercialization of cell and gene therapy products.

Matthew Lakelin

Matthew is a co-founder of TrakCel. Using his knowledge in handling and distribution of CGTs, he has assisted with the development of the technology platform, writing user stories for GMP-critical functions. Matthew provides a technical bridge between the software development side of the technology platform and the GxP application of the system.

Q: